References
- Tremaine WJ. Refractory IBD: medical management. Neth J Med 1997;50:S12–4.
- Sandborn WJ. Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol Suppl 1998;225:92–9.
- Sachar DB. Maintenance therapy in ulcerative colitis and Crohn’s disease. J Clin Gastroenterol 1995;20:117–22.
- Tanis AA. Azathioprine in inflammatory bowel disease, a safe alternative? Med Inflam 1998;7:141–4.
- Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;122:132–42.
- Van Deventer SJH, Tytgat GNJ. Drug treatment of Crohn’s disease. Ned Tijdschr Geneeskd 1998;142:1191–5.
- Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993;34: 1081–5.
- Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998;115:813–21.
- Present DH, Meltzer SJ, Krumholtz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111:641–9.
- Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn’s disease. Gut 1995;37:674–8.
- Posthuma EFM, Westendorp RGJ, Van der Sluys Veer A, Kluin-Nelemans JC, Kluin PhM, Lamers CBHW. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn’s disease with azathioprine. Gut 1995;36:311–3.
- Vassallo J, Galizia AC, Cuschieri P. Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species. Postgrad Med J 1996;72:680–1.
- Poveda F, Garcia-Alegria J, De Las Nievas MA, Villar E, Montiel N, Del Arco A. Disseminated histoplasmosis successfully treated with liposomal Amphotericin B following azathioprine therapy in a patient from a nonendemic area. Eur J Clin Microbiol Infect Dis 1998;17:357–9.
- Körner MM, Hirata N, Tenderich G, Minami K, Mannebach H, Kleesiek K, et al. Tuberculosis in heart transplant recipients. Chest 1997;111:365–9.
- Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983;5:216–26.
- Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994;106:435–9.
- Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994;58:301–6.
- Light RW, Hamm H. Pleural disease and acquired immune deficiency syndrome. Eur Respir J 1997;10:2638–43.
- Ferrer J. Pleural tuberculosis. Eur Respir J 1997;10:942–7.
- Wit D, Maartens G, Steyn L. A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion. Tuber Lung Dis 1992; 73:262–7.
- Valdes L, Alvarez D, San Jose E, Penela P, Valle JM, Garcia-Pazos JM, et al. Tuberculous pleurisy. A study of 254 patients. Arch Intern Med 1998;158: 2017–21.
- Seibert AF, Haynes J, Middleton R, Bass JB. Tuberculous pleural effusion. Twenty-year experience. Chest 1991;99:883–6.
- Ferrer Sancho J. Pleural tuberculosis: incidence, pathogenesis, diagnosis, and treatment. Curr Opin Pulm Med 1996;2:327–34.
- Blackmon GM, Raghu G. Pulmonary sarcoidosis: a mimic of respiratory infection. Semin Respir Infect 1995;10:176–86.
- Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ. Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of the literature. Arch Intern Med 1983;143:94–6.
- Roper WH, Waring JJ. Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 1955;71:616–35.